Physician profile
Yan Guo
NPI 1184816696
$2,001.28
in general payments reported to CMS, 2019-2025
18 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $88.13 · 2021: $32.13 · 2022: $238 · 2023: $301 · 2024: $385 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $462.81 | 2019-2022 | |
| Alcon Vision LLC | $444.32 | 2019-2025 | Rocklatan, Simbrinza, Rhopressa |
| Aerie Pharmaceuticals, INC. | $326.37 | 2019-2020 | |
| Abbvie INC. | $322.29 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $74.02 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Sun Pharmaceutical Industries INC. | $64.09 | 2024-2025 | |
| Thea Pharma INC. | $45.35 | 2024-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.49 | 2019 | |
| Shire North American Group INC | $28.84 | 2019 | |
| Sight Sciences, INC. | $28.00 | 2021-2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $26.81 | 2024 | Tyrvaya |
| Harrow Eye, LLC | $25.51 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $23.71 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $22.61 | 2025 | Xdemvy |
| Amgen INC. | $19.47 | 2025 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $18.03 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $17.92 | 2022 | |
| New World Medical,INC. | $10.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.